Related references
Note: Only part of the references are listed.Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth
Markus Loeffler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Gap Junction Communication between Autologous Endothelial and Tumor Cells Induce Cross-Recognition and Elimination by Specific CTL
Houssem Benlalam et al.
JOURNAL OF IMMUNOLOGY (2009)
Direct Antigen Presentation and Gap Junction Mediated Cross-Presentation during Apoptosis
Baoxu Pang et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-18-producing Salmonella inhibit tumor growth
M. Loeffler et al.
CANCER GENE THERAPY (2008)
Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease
Francesca Avogadri et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity
Gianluca Rotta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B
J. Fensterle et al.
CANCER GENE THERAPY (2008)
Gap junctions: Basic structure and function
Guelistan Mese et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Cyclic adenosine monophosphate is a key component of regulatory T cell mediated suppression
Tobias Bopp et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells
Ariadna Mendoza-Naranjo et al.
JOURNAL OF IMMUNOLOGY (2007)
Gap junction-mediated intercellular communication in the immune system
Joost Neijssen et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2007)
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses
Laurence Chapatte et al.
CANCER RESEARCH (2006)
Processing and presentation of tumor antigens and vaccination strategies
P van der Bruggen et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs
H Matsue et al.
JOURNAL OF IMMUNOLOGY (2006)
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation
NE Blachèr et al.
PLOS BIOLOGY (2005)
Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells
CJ Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cancer immunotherapy based on killing of Salmonella-infected tumor cells
F Avogadri et al.
CANCER RESEARCH (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cross-presentation by intercellular peptide transfer through gap junctions
J Neijssen et al.
NATURE (2005)
Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells
AL Ackerman et al.
NATURE IMMUNOLOGY (2005)
Identification of tumor antigens and T-cell epitopes, and its clinical application
A Paschen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Gap junctions - from cell to molecule
BJ Nicholson
JOURNAL OF CELL SCIENCE (2003)
Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo
G Rotta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma
U Pertl et al.
BLOOD (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Share Paper
